Alivus Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 15, 2025.
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Alivus Life Sciences approved the appointment of M/s. Bhadresh Shah & Associates, a peer-reviewed firm of Practicing Company Secretaries, as the Secretarial Auditors of the Company. The appointment is for a term of five consecutive financial years, from April 1, 2025 to March 31, 2030, and is subject to shareholder approval at a general meeting. Mr. Bhadresh Shah is a qualified Company Secretary with over 16 years of experience in secretarial and legal work and has been running his own practice since 2016.
This is a routine governance-related appointment with no material impact on the company's financials or operations. Shareholders will need to approve the appointment at the upcoming general meeting, which is standard practice.